Herb ·Moderate evidence ·Reviewed May 2026
The premier liver-protective herb, used for over 2,000 years. Silymarin complex protects hepatocytes from toxin damage and supports liver regeneration.
The bottom line
Evidence rating moderate. Most-documented uses: liver protection, detoxification support, antioxidant. 18 sources indexed (2001–2025), with 13 interaction records on file.
Core mechanism
Silymarin (especially silybin) stabilizes hepatocyte cell membranes by altering lipid composition. Stimulates ribosomal RNA polymerase to increase protein synthesis for liver regeneration. Potent antioxidant that increases intracellular glutathione by up to 35%. Inhibits NF-κB.14,5
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Standardized Silymarin Extract.
Assumes 200-600 mg silymarin/day. Vendor basis: NOW/iHerb, Vitacost, Life Extension, and Amazon marketplace; phytosome forms price higher. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Silymarin extract potency is not matched by normal culinary servings.
What to test, the optimal window inside the conventional range, and how long a response takes.
Silymarin (140 to 420 mg per day, standardized to 70 to 80 percent silymarin) lowers ALT and AST modestly in NAFLD and chronic liver disease RCTs.1,2
Pair with AST, GGT, and fasting insulin. Silybin phytosome (Siliphos) has better absorption than standard silymarin.
Milk thistle (silymarin) is expected to modestly lower AST in people with fatty liver or liver stress, with effects that are typically small, dose-dependent, and clearest when a baseline elevation exists.1,3
Fasting is not strictly required for AST, but draw at a consistent time of day. Avoid alcohol and strenuous exercise in the 48 hours before testing since both transiently raise AST. Retest after roughly 3 months on a stable dose.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Silymarin modestly lowers ALT and AST in NAFLD RCTs; antioxidant and anti-inflammatory hepatoprotection.9,2
Phytosome forms have better absorption.
Silymarin acts as an antioxidant on hepatocytes and has modestly lowered ALT and AST in some liver-injury trials.7,13
Have the cause of the enzyme elevation evaluated by a clinician first; this is adjunctive, not a substitute for diagnosis.
Silymarin may support hepatocyte antioxidant defenses, which could aid the liver's role in metabolizing and clearing estrogens.14,16
Generally well tolerated; mild GI upset is possible at higher doses.
Silymarin has antioxidant and membrane-stabilizing effects on hepatocytes, with traditional use for liver support but inconsistent clinical evidence.2,3
Evidence for preventing or treating hangovers specifically is weak; better studied in chronic liver conditions.
Silymarin supports hepatocyte function and may have a mild choleretic effect that increases bile flow.14,1
Primarily liver-supportive; the choleretic effect on fat digestion is modest and not well established.
Milk thistle (silymarin) has antioxidant properties studied for liver support, which may be relevant given alcohol's burden on the liver.1,3
Aimed at liver support, not craving reduction; it does not offset alcohol harm and is not a substitute for cutting down or professional care.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
Silymarin (preferably silybin phytosome) modestly lowers ALT and AST in NAFLD and chronic liver disease through antioxidant and membrane stabilization mechanisms.1,2
Silymarin from Milk Thistle has antioxidant activity in the liver and may help support intracellular glutathione and hepatocyte membrane stability, complementing the other detoxification inputs. Human outcome data are mixed, so it is included as a supportive adjunct.16,1
Milk thistle is often used for liver antioxidant support, but trials in alcohol-related liver disease have not proven clear clinical outcome benefit. Treat it as optional liver support, not a way to make alcohol safer.16,3
Both support liver health through glutathione-related mechanisms. NAC provides glutathione precursor; silymarin protects liver cells and supports glutathione levels.
Recommendation: Effective liver support combination. Take together for hepatoprotective benefit.
Milk thistle (silymarin) inhibits CYP enzymes that metabolize berberine, potentially increasing its bioavailability and duration of action.
Recommendation: Combine for enhanced metabolic support. Silymarin may increase berberine bioavailability.
Both are hepatoprotective compounds that support liver health through complementary antioxidant and anti-inflammatory mechanisms.
Recommendation: Effective liver support combination. Both protect hepatocytes and support detoxification.
Both are hepatoprotective compounds that support liver health through complementary antioxidant and anti-inflammatory mechanisms.
Recommendation: Effective liver support combination. Both protect hepatocytes and support detoxification.
Milk thistle (silymarin) inhibits CYP enzymes that metabolize berberine hcl, potentially increasing its bioavailability and duration of action.
Recommendation: Combine for enhanced metabolic support. Silymarin may increase berberine hcl bioavailability.
Milk thistle (silymarin) is often taken for liver support during alcohol use, but evidence does not show it prevents alcohol-related liver damage, and its perceived protection may encourage continued drinking.
Recommendation: Do not treat milk thistle as protection that makes drinking safe. The most effective step for alcohol liver injury is reducing or stopping alcohol; seek medical advice.
Sulforaphane and silymarin (the active fraction of milk thistle) both activate Nrf2-driven cytoprotective and antioxidant defenses in the liver, providing complementary hepatoprotective support.
Recommendation: Can be combined to support liver antioxidant capacity. No timing restriction is needed.
Schisandra lignans and milk thistle silymarin both support hepatocyte protection and antioxidant defense, giving complementary hepatoprotective effects.
Recommendation: Commonly used together for liver support. If on drugs with a narrow therapeutic window, monitor because both can influence hepatic enzyme activity.
DIM shifts estrogen metabolism toward 2-hydroxylation by inducing CYP1A enzymes, while milk thistle silymarin can mildly inhibit some CYP and glucuronidation enzymes, so co-use may modestly alter estrogen handling and the clearance of other liver-metabolized compounds.
Recommendation: Generally usable together, but be aware milk thistle may modestly modulate the enzymes DIM acts on. If also taking hormone therapy or narrow-margin CYP-metabolized medications, consult a clinician before combining.
Silymarin from milk thistle inhibits CYP3A4, CYP2C9, UGT enzymes, and P-glycoprotein in vitro, and clinical pharmacokinetic studies have shown modest interactions with substrates such as losartan and nifedipine. Because fluconazole itself inhibits CYP3A4 and CYP2C9, layering milk thistle may amplify suppression of drug metabolism while doing little to mitigate fluconazole hepatotoxicity risk in any RCT-proven way.
Recommendation: If you take milk thistle for liver support, discuss with your prescriber before continuing during fluconazole therapy. Do not rely on it to prevent fluconazole-induced liver injury; instead monitor liver enzymes as your prescriber advises.
A 6-month RCT in 59 patients found that adding silymarin 200 mg three times daily to glyburide improved HbA1c and postprandial glucose more than glyburide alone. Silymarin is a weak CYP2C9 inhibitor in vitro and reduces fasting glucose independently. The combination meaningfully amplifies glyburide's hypoglycemic effect, and glyburide already carries the highest hypoglycemia risk among sulfonylureas, especially in older adults and renal impairment.
Recommendation: Tell your prescriber before adding milk thistle on glyburide. Monitor fasting and bedtime glucose for at least 4 weeks and ask whether your glyburide dose should be reduced. Avoid the combination entirely if you have CKD or are over 75.
Glipizide is metabolized primarily by CYP2C9. Silymarin (milk thistle) inhibits CYP2C9 in vitro and has independent hypoglycemic activity demonstrated in type 2 diabetes meta-analyses. The combination can raise glipizide exposure and amplify its glucose-lowering, producing hypoglycemia especially in older adults or after missed meals.
Recommendation: Tell your prescriber before adding milk thistle on glipizide. Monitor fingerstick glucose more often during the first 4 weeks and ask whether the glipizide dose should be reduced.
Numbered references. Citations throughout the page link here.
Frounchi N, Mahmoodpoor F, Zakavi SS et al.. Nephroprotective Effects of Silymarin: A Systematic Review and Meta-Analysis. Biochemistry. Biokhimiia. 2025
26 RCTs (2,375 patients) showed silymarin attenuated liver damage and improved liver histology in NAFLD/NASH, with decreased ALT and AST levels.
Mohammadi S, Ashtary-Larky D, Asbaghi O et al.. Effects of silymarin supplementation on liver and kidney functions: A systematic review and dose-response meta-analysis. Phytotherapy research : PTR. 2024
Huang Q, An Z, Xin X et al.. The Effectiveness of Curcumin, Resveratrol, and Silymarin on MASLD: A Systematic Review and Meta-Analysis. Food science & nutrition. 2024
Singh M, Kadhim MM, Turki Jalil A et al.. A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity. Cancer cell international. 2023
Among various nutraceuticals evaluated, silymarin demonstrated favorable effects on lipid parameters including reduction in total cholesterol and LDL in this network meta-analysis.
Mohtashaminia F, Amini MR, Sheikhhossein F et al.. Effects berberine-silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials. Clinical nutrition ESPEN. 2022
The berberine-silymarin combination significantly reduced total cholesterol, LDL cholesterol, triglycerides, and fasting blood glucose compared to placebo in patients with metabolic disorders.
Wei F, Liu SK, Liu XY et al.. Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2013
Saller R, Brignoli R, Melzer J et al.. An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forschende Komplementarmedizin (2006). 2008
29 RCTs (3,846 participants) showed silymarin's impact on liver enzymes is context-dependent, with strongest evidence in NAFLD patients.
Silymarin stabilizes hepatocyte cell membranes, stimulates protein synthesis for liver regeneration, and increases intracellular glutathione.
Silymarin is safe at doses up to 700 mg three times daily for 24 weeks with only mild GI adverse effects; no serious adverse events reported.
Silymarin acts as antioxidant by reducing free radical production, has antifibrotic activity, and may act as toxin blockade agent; in patients with cirrhosis, treatment was associated with reduced liver-related deaths.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack